Anti-diarrhea active ingredients of plantain and their application

Identification of luteolin and baicalin in plantain by ultra-high performance liquid chromatography-time-of-flight mass spectrometry, regulate the activities of Na+/K+-ATPase and creatine kinase, and solve the nonspecificity and disadvantages of diarrhea drug treatment in the prior art. The reaction problem has achieved significant anti-diarrhea effect.

CN111170977BInactive Publication Date: 2024-11-08NORTHEAST AGRICULTURAL UNIVERSITY
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN201911114532.7
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2019-11-14
Publication Date
2024-11-08
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

The existing diarrhea drug treatment is nonspecific and has adverse reactions. It lacks targeted treatment for Na+/K+-ATPase, AQP4 and opioid receptors. The anti-diarrhea active ingredients in plantain are not clear, which limits the formulation of quality standards and mechanisms. Research.

Method used

Ethyl plantaine extract was identified by ultra-high performance liquid chromatography-time-of-flight mass spectrometry, and 14 monomeric compounds were isolated and identified, among which luteolin and baicalin had significant anti-diarrhea effects, and regulated Na+/K+-ATP The activity and gene expression of enzymes and creatine kinases exert anti-diarrhea effects.

Benefits of technology

Luteolin and baicalin isolated from plantain significantly reduce the volume and weight of intestinal content, increase Na+/K+-ATP enzyme activity, improve diarrhea induced by castor oil, and provide natural anti-diarrhea drug ingredients. Avoid adverse reactions from chemical drugs.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN111170977B_ABST
    Figure CN111170977B_ABST
Patent Text Reader

Abstract

The present invention discloses an effective anti-diarrhea ingredient of plantain and its application. The present invention identifies the main chemical components of the ethyl acetate extraction part and the remaining part of plantain by ultra-high performance liquid chromatography-time-of-flight mass spectrometry, thereby determining 14 monomer components of the effective part of plantain, and then screens out 3 effective anti-diarrhea ingredients, namely baicalein, caffeic acid and luteolin, by molecular docking technology. Through a mouse diarrhea model test induced by castor oil, it was found that luteolin and baicalein have significant anti-diarrhea effects, but the anti-diarrhea effect of caffeic acid is not obvious. The present invention further provides the application of luteolin or baicalein separated from plantain in the preparation of anti-diarrhea drugs.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the separation, identification and application of effective anti-diarrhea components of plantain, and belongs to the field of separation and application of effective anti-diarrhea components of plantain. Background Art

[0002] Diarrhea is a disease characterized by increased frequency of bowel movements, which is a cause of morbidity and mortality in developing countries, especially in many young animals such as piglets and lactating calves. In addition, diarrhea is a major cause of morbidity and ulcers in the elderly and in HIV-infected patients. The physiological mechanisms leading to diarrhea include increased intestinal motility, increased fluid volume in the intestinal lumen, and reduced absorption of water and electrolytes.

[0003] Na + / K + -ATPase is present in the basolateral membrane of intestinal cells and provides the driving force for the active transport of many electrolytes. Inhibition of this intestinal enzyme may be crucial for the regulation and absorption of Na+ and K+ in the intestine and may lead to accumulation of intestinal fluid, thereby inducing diarrhea (Rachmilewitz, D., F. Karmeli, and P. Sharon, Decreased colonic Na-K-ATPase activity in active ulcerative colitis. Israel journal of medical sciences, 1984. 20(8): p. 681-4. Yakubu, MT and SS Ssalimon, Antidiarrhoeal activity of aqueous extract of Mangifera indica L. leaves in female albinorats. Journal of Ethnopharmacology, 2015. 163: p. 135-141. Yakubu, MT, et al., Antidiarrhoeal Activity of Musa paradisiaca Sap in Wistar Rats. Evidence-Based Complementary and Alternative Medicine, 2015.). So far, few drugs have been developed or studied to inhibit Na+ and K+. + / K +-ATPase as a target for the treatment of diarrhea; AQP4 is a water channel protein that participates in water metabolism in the intestine. If the expression of this protein is inhibited, it will lead to disorders in water absorption and secretion in the intestine, promote intestinal fluid accumulation and induce diarrhea (Zhang, D., et al., Aquaporin-4 Is Downregulated in the Basolateral Membrane of Ileum Epithelial Cells during Enterotoxigenic Escherichia coli-Induced Diarrhea in Mice. Frontiers in Microbiology, 2018.8.); Opioid receptors are involved in regulating intestinal motility. Drugs binding to opioid receptors can inhibit intestinal peristalsis and prolong the retention time of intestinal contents, thereby relieving diarrhea (Fujita, W., et al., Molecular characterization of eluxadoline as a potential ligand targeting mu-delta opioid receptor heteromers. Biochemical Pharmacology, 2014. 92(3): p.448-456.). Therefore, these three proteins are potential targets for drugs to treat diarrhea. Currently, drug treatments for diarrhea are non-specific and usually aim to reduce the inconvenience caused by frequent bowel movements, dehydration and discomfort.

[0004] Although there are some effective drugs such as chemical drugs all over the world, these drugs can induce adverse reactions, and natural plants have become the focus of recent attention because of their safety and availability. To avoid diarrhea, doctors and patients in many developing countries (such as China) still rely on traditional medicines. For this reason, the World Health Organization has launched a diarrhea control program involving the use of traditional herbal medicines.

[0005] Plantain is a natural medicinal plant with abundant resources, low price, many active ingredients and targets, low toxicity, and not easy to develop drug resistance. Plantago contains some biologically active compounds, such as flavonoids, caffeic acid derivatives, iridoid glycosides, terpenoids, alkaloids and some organic acids (Ronsted, N., et al., Chemotaxonomy of Plantago. Iridoid glucosides and caffeoyl phenylethanoidglycosides. Phytochemistry, 2000. 55(4): p. 337-348. Taskova, R., et al., Iridoid patterns of genus Plantago L. and their systematic significance. Zeitschrift fur Naturforschung. C, Journal of biosciences, 2002. 57(1-2): p. 42-50. Grubesic, RJ, et al., Simultaneous RP-HPLC-DAD Separation, and Determination of Flavonoids and Phenolic Acids in Plantago L. Species. Chemistry & Biodiversity, 2013. 10 (7): p. 1305-1316.). At present, the research on plantain at home and abroad mainly focuses on antioxidant, anti-inflammatory and antibacterial aspects (Goncalves, S., et al., Antioxidant activity and verbascoside content in extracts from two uninvestigated endemic Plantago spp. Industrial Crops and Products, 2015. 65: p. 198-202). Although the pharmacopoeia records the anti-diarrhea effect of plantain (Pharmacopoeia of the People's Republic of China (2010 edition)), and plantain is often used in folk treatment of piglet diarrhea, there is no relevant literature report and the active ingredients are unclear, which limits the formulation of quality standards and the study of mechanisms. Summary of the invention

[0006] The main purpose of the present invention is to isolate a monomer compound having anti-diarrhea activity from a plantain extract;

[0007] The second purpose of the present invention is to use the separated monomeric compounds to prepare anti-diarrhea drugs;

[0008] The above object of the present invention is achieved through the following technical solutions:

[0009] The present invention firstly identifies the main chemical components of the ethyl acetate extraction part and the remaining part of Plantain by ultra-high performance liquid chromatography-time-of-flight mass spectrometry: in positive and negative ion modes, most compounds can produce [M+H] + or [MH] - Molecular ion, then at 5×10 -6 The ion mass and isotope abundance ratio were accurately measured by a high-resolution mass spectrometer within the error range; finally, the molecular formula of the compound was determined based on the accurate mass and isotope abundance ratio by the Formula Finder function of Peakview 2.0 software. For compounds with reference standard substances, the retention time and the structure of the secondary mass spectrum information were further confirmed; for compounds for which reference standard substances could not be obtained, the fragment composition was first calculated according to the accurate mass of the fragment ions and the mass spectra of compounds with similar structures were studied by comparing the possible structural formulas given by the chemical database. The mass spectrometry features were analyzed by Peakview 2.0 software, and the structure of the compound was estimated by combining the similarity of the secondary spectra. Finally, the present invention determined 14 monomer components of the effective part of Plantago, which were mainly divided into 3 phenylethanol glycosides and 3 triterpenes, 6 flavonoids and 2 organic acids; thereafter, for the 3 proteins related to diarrhea, the 3 monomer components of scutellariae, caffeic acid and luteolin were screened out by molecular docking technology for further research.

[0010] Castor oil is an effective laxative and is widely used to study symptoms related to diarrhea and motility in intestinal transit. Castor oil-induced diarrhea can be attributed to its active component, ricinoleic acid. In the intestinal lumen, castor oil is hydrolyzed by lipase to ricinoleic acid, an anticoagulant of the intestinal mucosa that interacts with several endogenous mediators to induce diarrhea. Castor oil increases fluid secretion via adenylate cyclase as well as cyclic adenosine monophosphate (cAMP) levels. In addition, it reduces Na+ in the small intestine and colon. + / K + -ATPase activity, inhibiting the + and K + In order to study the anti-diarrhea effect of baicalein, caffeic acid and luteolin isolated from plantain, the present invention conducted a mouse diarrhea model test induced by castor oil. The test results showed that among the three monomer components, luteolin and baicalein had significant anti-diarrhea effect, but the anti-diarrhea effect of caffeic acid was not obvious.

[0011] In order to clarify the anti-diarrhea mechanism of luteolin and baicalein, the present invention conducted a castor oil-induced intestinal fluid test in rats. According to the test results, compared with the model group, the volume and weight of intestinal contents after luteolin and baicalein treatment were significantly reduced, indicating that luteolin and baicalein are involved in at least one major mechanism related to acute diarrhea, such as Na + / K + -ATPase activity inhibition, increase intestinal motility. Castor oil-induced diarrhea is due to the formation of ricinoleic acid in the intestinal lumen, which leads to changes in intestinal homeostasis. Ricinoleic acid causes Na + / K + -ATPase normal function inhibition leads to changes in electrolyte permeability and intestinal smooth muscle contraction, inducing severe diarrhea. The results of this experiment showed that luteolin and baicalein significantly increased Na + / K + -ATPase activity, indicating that both luteolin and scutellariae baicalenol can bind to Na + / K + -ATPase has good binding ability, which is consistent with the molecular docking results.

[0012] Creatine kinase (CK) maintains cellular energy homeostasis by providing a temperature and spatial energy buffer through the creatine kinase phosphate (CK / PCR) system and is responsible for providing the correct function of adenosine triphosphate (ATP) ATPase, such as sodium and potassium (Na + / K + -ATPase) and hydrogen (H+-ATPase) pumps, leading to Na + , K + In order to further clarify whether luteolin and baicalein improve Na + / K + -ATPase activity. The experimental results of the present invention show that luteolin and baicalein can improve the decrease of creatine kinase activity induced by castor oil and increase Na + and K + concentration, indicating that luteolin and scutellariae can upregulate creatine kinase and Na + / K + -ATPase activity, increasing Na + and K + concentration, thereby exerting an anti-diarrhea effect.

[0013] Na + / K + -ATPase and creatine kinase activity results showed that luteolin and baicalein could significantly upregulate the relative gene expression levels of ckb and Atp1b3, which means that luteolin and baicalein can change the Na + / K+ -ATPase and creatine kinase activities, thereby exerting an anti-diarrhea effect.

[0014] In summary, luteolin or baicalein isolated from plantain can regulate Na + / K + -ATPase and creatine kinase activities and their gene expression levels play an anti-diarrhea effect.

[0015] Therefore, the present invention provides an effective anti-diarrhea ingredient of plantain, which is selected from any monomer compound of luteolin, baicalein or caffeic acid or a mixture of more than one monomer compound in any proportion; preferably, the effective anti-diarrhea ingredient of plantain is selected from any monomer compound of luteolin or baicalein or a mixture of luteolin and baicalein in any proportion.

[0016] The luteolin, baicalein or caffeic acid described in the present invention can be prepared by methods disclosed in existing literature, or can be separated from plantain according to the method provided in this specification.

[0017] For reference, the present invention provides a method for isolating luteolin, scutellariae or caffeic acid from plantain, the method comprising:

[0018] The ethyl acetate fraction of Plantago asiatica was separated and identified by ultra-performance liquid chromatography-time-of-flight mass spectrometry.

[0019] Among them, the separation and identification method is preferably: separation on a Waters Acquity UPLC BEH C18 column, eluted with 0.1% formic acid and acetonitrile; time-of-flight mass spectrometry and electrospray ionization source are used for analysis in positive and negative ion modes; targeted search and non-target search are performed by Peakview 2.0 / masterview1.0 or Markerview 1.2.1 software, and then the composition of the compound is determined by the accurate mass and isotope abundance ratio of the software target screening function; the structure of the separated monomer compound is determined by analyzing MS / MS fragments or comparing them with standard substances and references.

[0020] A further object of the present invention is to provide an anti-diarrhea pharmaceutical composition, which is composed of a therapeutically effective amount of luteolin or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier; or a therapeutically effective amount of baicalein or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier; or a therapeutically effective amount of caffeic acid or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier; or a therapeutically effective amount of a mixture of more than one of luteolin, baicalein or caffeic acid in any proportion and a pharmaceutically acceptable carrier.

[0021] After a pharmaceutically acceptable amount of luteolin, baicalein or caffeic acid is combined with a pharmaceutically acceptable carrier or diluent, it is prepared into any suitable pharmaceutical composition according to the conventional pharmaceutical preparation method in the art; the composition is usually suitable for oral administration and injection administration, and is also suitable for other administration methods; the pharmaceutical composition can be prepared into various preparation forms such as tablets, capsules, powders, granules, lozenges, suppositories or oral liquids according to the conventional preparation method of pharmaceutical preparations. According to different administration methods, the pharmaceutical composition of the present invention can contain 0.1%-99% by weight, preferably 10-60% by weight of luteolin, baicalein or caffeic acid monomer compounds. BRIEF DESCRIPTION OF THE DRAWINGS

[0022] Figure 1 Molecular docking results of baicalein, luteolin, caffeic acid and anti-diarrhea related proteins; (A) Baicalein and Na + / K + -ATPase binding, (B) Luteolin and Na + / K + -ATPase binding, (C) baicalein and opioid receptor binding (D) caffeic acid and AQP4 binding.

[0023] Figure 2 Evaluation of the anti-diarrhea effects of baicalein, luteolin, and caffeic acid monomer components.

[0024] Figure 3 Pathological sections of mouse colon tissue; (A) luteolin group; (B) baicalein group; (C) caffeic acid group; (D) three-component mixed group; (E) negative control (ethanol) group; (F) positive control group; (G) blank group; (H) pathological scores of each group.

[0025] Figure 4 Comparison of intestinal fluid accumulation, enzyme activity, ion concentration and enzyme gene level between the luteolin and baicalein treatment groups and the model group; (A-B) Volume and weight of intestinal fluid accumulation; (C-D) Determination of enzyme activity in the rat small intestine; (E-F) Determination of ion concentration in the rat small intestine; (G) Determination of enzyme gene level in the rat small intestine.

[0026] Figure 5 Results of the mouse intestinal motility test.

[0027] Figure 6 The structural formula of scutellarin.

[0028] Figure 7 Structural formula of luteolin.

[0029] Figure 8 The structural formula of caffeic acid. DETAILED DESCRIPTION

[0030] The present invention will be further described below in conjunction with specific embodiments, and the advantages and features of the present invention will become clearer as the description proceeds. However, these embodiments are exemplary only and do not constitute any limitation to the scope of the present invention. It should be understood by those skilled in the art that the details and forms of the present invention may be modified or replaced without departing from the spirit and scope of the present invention, but these modifications and replacements all fall within the scope of protection of the present invention.

[0031] Experimental Example 1: Isolation, identification and anti-diarrhea mechanism study of effective anti-diarrhea ingredients in Plantain

[0032] 1 Test materials

[0033] Plantain was obtained from local farmers in Heilongjiang Province, China, and then sorted, cleaned and cut into small pieces. The water content of the original sample was 8.0%. Luteolin, scutellariae and caffeic acid were purchased from Solarbio (purity ≥ 99%).

[0034] 2 Test methods

[0035] 2.1 Ultra-high performance liquid chromatography-time-of-flight mass spectrometry

[0036] The main chemical components of the effective parts of Plantago asiatica (ethyl acetate part and the remaining part) were identified by ultra-high performance liquid chromatography-time-of-flight mass spectrometry. Separation was performed on a Waters Acquity UPLC BEH C 18 column (100 mm × 2.1 mm, 1.7 μm), eluted with 0.1% formic acid (A) and acetonitrile (B). Time-of-flight mass spectrometry and electrospray ionization (ESI) source were used for analysis in positive and negative ion modes; targeted and non-targeted searches were performed by Peakview 2.0 / masterview1.0 or Markerview 1.2.1 software, and the composition of the compounds was determined by the accurate mass and isotope abundance ratio of the software's target screening function. Their structures were determined by analyzing MS / MS fragments or comparing them with standard substances and references (Huo, J.-H., et al., Identification and characterization of major constituents in Juglans mandshurica using ultra performance liquid chromatography coupled with time-of-flight mass spectrometry (UPLC-ESI-Q-TOF / MS). Chinese Journal of Natural Medicines, 2018. 16(7): p. 525-545.).

[0037] 2.2 Molecular docking

[0038] 2.2.1 Homology modeling

[0039] The structural information of the target protein is very important, and homology modeling technology is widely used to model proteins. Currently, there is no available tertiary structure of opioid receptors and AQP4 receptors in the Protein Data Bank (PDB). Therefore, the successful construction of the 3D model of GS becomes the key to subsequent research. The amino acid sequence of GS was retrieved from the UNIPRO database (http: / / www.uniprot.org). In order to obtain the optimal template for homology modeling, the NCBI-BLAST server (http: / / blast.ncbi.nlm.nih.gov / ) was used to search the PDB protein database for sequence similarity. The model was generated using EasyModeller4.0 (Pourseif, MM, et al., A novel B-and helper T-cell epitopes-based prophylactic vaccine against Echinococcus granulosus. BioImpacts: BI, 2018.8(1): p.39-52.), which integrates the Modeller program in the back end and is considered to work well within the recognition range of 30-40% sequence similarity.

[0040] 2.2.2 Model optimization and evaluation

[0041] Since protein models generated by homology modeling often produce unfavorable bond lengths, bond angles, torsion angles, and contact points, it is important to minimize the model energy, regularize the local bond and angle geometries, and relax tight contacts on the geometric chain. In order to verify the accuracy of the predicted opioid receptor and AQP4 receptor structures, the protein structures were optimized and evaluated through the server. The GS structure was submitted to the Chrion (http: / / redshift.med.unc.edu / chiron / index.php) server for model optimization, and the optimized GS model was submitted to the structure analysis and verification server SAVES (http: / / servicesn.mbi.ucla.edu / SAVES / ), and the model was verified using the optional PROCHECK

[10] program.

[0042] 2.2.3 CDOCKER molecular docking

[0043] The CHARMM-based CDOCKER (Li, K., et al., Rational Design of Novel Phosphoinositide 3-kinase Gamma (PI3Kgamma) Selective Inhibitors: A Computational Investigation Integrating 3D-QSAR, Molecular Docking and Molecular Dynamics Simulation. Chemistry & biodiversity, 2019.) method was used for molecular docking. CDOCKER is a protein-ligand molecular docking program written in the CHARMM script in the DiscoveryStudio3.0 (DS3.0) software. Among them, the proteins (sodium-potassium ATPase, opioid receptors and AQP4 receptors) and small molecules obtained by mass spectrometry were hydrogenated and treated with electric fields, and the molecular docking program was performed using DS3.0 software (Cui, W.-Q., et al., Discovery of Potential Anti-infective Therapy Targeting Glutamine Synthetase in Staphylococcus xylosus. Frontiers in Chemistry, 2019.7(381)).

[0044] 2.3 Experimental animals

[0045] Male or female Kunming mice (18-22 g) and Wistar rats (180-200 g) were obtained from the Animal Center of Harbin Medical University (Harbin, China). They were kept in plastic cages at 22 ± 2 °C with free access to food and water. This experiment was conducted in accordance with the “Regulations on the Administration of Laboratory Animals” (National Science and Technology Commission of China, 1988) and approved by the Ministry of Health of China, in accordance with the NIH guidelines and the relevant regulations of the University Institutional Animal Care and Use Committee.

[0046] 2.4 Mouse diarrhea model test

[0047] The effects of three monomers on diarrhea induced by castor oil were studied. Kunming mice were fasted for 18 hours, free access to water, and randomly divided into 8 groups (6 mice in each group). The three monomer drug groups were orally administered with scutellarin (1.75 mg / kg), caffeic acid (332.5 mg / kg), and luteolin (5 mg / kg), respectively; the three monomer mixed groups were orally administered with a mixture of the three monomers in a certain proportion; the model group was orally administered with castor oil (10 mL / kg); the positive group was administered with loperamide hydrochloride (2 mg / kg); and the negative group was administered with ethanol (10%). After 30 minutes, 0.2 mL of castor oil (voucher sample number 20160920) was administered to each mouse to induce diarrhea. Mice that were not given drugs and castor oil were used as blank groups. The animals were then placed in separate cages lined with oil-proof paper, and the total number of defecation, the number of loose stools, and the loose stool inhibition rate were calculated, and each group was repeated three times. After 4 hours of observation, the animals were euthanized and colon tissues were collected.

[0048] 2.5 Histopathology

[0049] Using the same mice as those used in the castor oil-induced diarrhea test, the colons were collected, fixed in 10% formalin, and subjected to routine histological processes of paraffin embedding and light microscopy. In addition, histopathological scoring, including edema, degree of injury, leukocyte infiltration, crypt abscesses, and goblet cell loss, was performed (Lu, Y., et al., Camboginsuppresses dextran sulphate sodium-induced colitis by enhancing Treg cellstability and function. British Journal of Pharmacology, 2018. 175(7): p. 1085-1099.). In this grading system, the severity of inflammation is graded from 0 to 3 (0, 0, no inflammation; 1, mild inflammation; 2, moderate inflammation; 3, severe inflammation), as is the degree of injury (0, no injury; 1, mucosal injury; 2, mucosal and submucosal injury; 3, transmural injury). A scale of 0 to 4 was used (0, no damage; 1, basal one-third damaged; 2, basal two-thirds damaged; 3, only the surface epithelium intact; 4, complete loss of crypts and epithelial cells). The total histopathology score was determined from the sum of the scores for each parameter to reflect the overall degree of damage for each sample.

[0050] 2.6 Rat intestinal effusion test

[0051] The castor oil-induced intestinal fluid accumulation model experiment in the reference (Lu, Y., et al., Cambogin suppresses dextran sulphatesodium-induced colitis by enhancing Treg cell stability and function. British Journal of Pharmacology, 2018. 175 (7): p. 1085-1099.) was conducted. The rats were fasted for 18 hours, with free access to water, and randomly divided into 4 groups, with 6 rats in each group. Groups 1 and 2 were orally administered with 1.75 mg / kg scutellarin and 5 mg / kg luteolin; groups 3 and 4 were orally administered with an equal volume of water. One hour later, all groups except group 4 received 1 mL of castor oil. Three hours later, the animals were euthanized and resected, with the small intestine cut from the pylorus to the cecum. The intestinal contents were collected into graduated tubes and their volume and weight were measured. The calculation was performed according to the following formula: Inhibition rate of intestinal fluid volume (%) = [(AB) / A] x 100, wherein A represents the average fluid volume after castor oil administration, and B represents the average fluid volume after drug treatment.

[0052] 2.7 Na in the small intestine + / K + -Assays for ATPase and creatine kinase activities

[0053] The small intestine of each group of rats was collected, and the intestinal supernatant was prepared. + / K + -ATPase ELISA kit to measure Na + / K + -ATPase activity (Lu, Y., et al., Cambogin suppresses dextran sulphate sodium-induced colitis by enhancing Treg cell stability and function. British Journal of Pharmacology, 2018.175(7):p.1085-1099.).

[0054] Add 50 μL of standards of different concentrations to the standard wells, add 10 μL of test samples to the test sample wells, and then add 40 mL of sample diluent. No reagent is added to the blank wells. Add 100 μL of HRP-conjugate reagent to each well, cover with strip adhesive and incubate at 37°C for 60 minutes. Drain each well filled with wash solution (400 μL) and wash four times, for a total of five washes. For good performance, the liquid must be completely removed at each step. Add 50 mL of chromogen solution A and chromogen solution B to each well, then mix gently and incubate at 37°C in the dark for 15 minutes. Finally, add 50 μL of stop solution to each well. Read the optical density (OD) at 450 nm within 15 minutes using a microtiter plate reader. In an Excel worksheet, the standard concentration is used as the abscissa and the OD value is plotted as the ordinate. Plot a linear regression curve for the standards and calculate the concentration value of each sample based on the curve equation. With Na + / K + Similar to the rat creatine kinase, creatine kinase was determined using the rat creatine kinase ELISA kit.

[0055] 2.8 Real-time quantitative PCR

[0056] The steps of total RNA extraction and cDNA synthesis were performed according to the manufacturer's instructions. To investigate the effects of luteolin and wild baicalein on the gene levels of Na+ / K+-ATPase and creatine kinase, ckb and Atp1b3 (Table 2) were selected for real-time quantitative PCR assay. The reaction conditions were 95°C, 10 min, 40 cycles; 95°C, 15 s; 50-60°C, 1 min. The assay was repeated 3 times.

[0057] 2.9 Na in the small intestine + and K + Determination of concentration

[0058] Sodium ion determination by sodium test kit. 0.1g tissue was added to 1mL deionized water and homogenized in an ice water bath, centrifuged at 3500rpm for 10 minutes, and the supernatant was taken for testing. 300μL of reagent was added to each standard tube and sample tube, 20μL of standard solution and supernatant were added to each standard tube and sample tube, and then 200μL of accelerator was quickly added within 15 seconds and diluted with 1mL of ethanol. After mixing, the absorbance of each tube was measured at 620nm using a spectrophotometer.

[0059]

[0060] A represents the OD of the measuring tube, B represents the OD of the standard tube, C represents the concentration of the standard, and D represents the dilution factor before the sample is tested. The determination of potassium ions is based on the potassium test kit. The wavelength is 450nm.

[0061] 2.10 Mouse intestinal motility test

[0062] The mice were fasted for 18 hours and had free access to water. The animals were divided into 4 groups, with 6 animals in each group. All groups except Group 4 were orally administered with castor oil. One hour later, each animal in Group 1 was orally administered with scutellarin (1.75 mg / kg), each animal in Group 2 was orally administered with luteolin (5 mg / kg), and each animal in Groups 3 and 4 was given the same volume of water. One hour later, the animals were orally administered with a charcoal suspension containing 10% activated carbon suspended in 5% gum arabic (0.2 mL / animal). After 30 minutes, the animals were euthanized and the small intestine was immediately separated. The advancement distance of the charcoal powder in the small intestine and the total length of the intestine were measured, and the charcoal powder advancement rate represents the percentage of the charcoal powder advancement distance relative to the total length of the small intestine.

[0063] 2.11 Data and statistical analysis

[0064] All experimental data are expressed as mean ± SD. SPSS Statistics 17.0 was used to determine the differences between the two groups by Student's t-test. In addition, GraphPad Prism 5.0 software was used to draw pictures. P < 0.05 was used to indicate a statistically significant difference.

[0065] 3 Test results

[0066] 3.1 Ultra-high performance liquid chromatography-time-of-flight mass spectrometry

[0067] According to Table 1, there are 14 components in the effective parts of Plantain Herba as identified by mass spectrometry, including plantagoside, verbascoside, 6-hydroxy-luteolin, baicalin, ursolic acid, rehmannia glutinosa, homoplanin, apigenin, baicalin, caffeic acid, ferulic acid, luteolin, akebia phenylethanol glycoside B, and daphnoside A. However, among the numerous chemical components, it is still unclear which effective ingredient or group of effective ingredients plays a role.

[0068] Table 1 Results of the determination of the quality of Plantain liquid

[0069]

[0070] 3.2 Molecular docking

[0071] according to Figure 1 (A) Scutellarin and Na + / K + -ATPase's TYP-43 amino acid, GLY-848 amino acid, and TRP-32 amino acid form stable hydrogen bonds; Figure 1 (B) shows that luteolin and Na + / K +-ATPase TYR-43 amino acid and TRP-32 amino acid form stable hydrogen bonds; this indicates that baicalein, luteolin and Na + / K + -ATPase binds well; Figure 1 (C) shows that baicalein forms stable hydrogen bonds with amino acids at LYS-236, LYS-306, ASP-57, ASP-150, and TYR-151 of opioid receptors, indicating that baicalein binds well to opioid receptors; Figure 1 (D) shows that caffeic acid forms stable hydrogen bonds with the ASN-184 amino acid, HIS-66 amino acid, and GLY-65 amino acid of AQP4, indicating that caffeic acid and AQP4 bind well. Molecular docking with scutellarin, luteolin, and caffeic acid and other small molecules for the three proteins related to diarrhea screened out three monomer components, namely luteolin, scutellarin, and caffeic acid.

[0072] 3.3 Anti-diarrhea effects of three monomers: luteolin, scutellarin, and caffeic acid

[0073] from Figure 2 From A to C, we can see that there is no difference between the scutellarin, caffeic acid and luteolin groups and the model group in terms of the time of first diarrhea, but in terms of the number of loose stools and the total number of defecations, the differences between them and the control group are extremely significant except for caffeic acid. In addition, the loose stool inhibition rates of the scutellarin, luteolin and caffeic acid groups were 24.55%, 54.55% and 9.09%, respectively. Therefore, luteolin and scutellarin with better effects were selected for the next study.

[0074] 3.4 Histopathological analysis

[0075] In order to further verify the anti-diarrhea effect of the monomer components, pathological section observation was performed in this study. Figure 3 The pathological sections showed that compared with the control group, the model group had intestinal epithelial cells shed, glands and crypts disappeared, mucosal cell structure was severely damaged, submucosal hyperplasia, vascular dilation, and mucosal thickness was significantly reduced, while the drug group significantly alleviated this symptom; among them, luteolin and baicalein had more significant effects. According to the histopathological scoring results, the score of the model group was significantly higher than that of the blank group, while the scores of the three monomer component groups were significantly lower than those of the model group, which showed that baicalein, caffeic acid, luteolin and their mixtures could significantly improve the colon tissue damage caused by castor oil, among which baicalein had the best effect.

[0076] 3.5 Changes in intestinal fluid

[0077] Figure 4Compared with the model group, the volume and weight of intestinal contents after treatment with luteolin and baicalein were significantly reduced in A-B. In addition, the inhibition rates of intestinal contents in the luteolin and baicalein groups were 25.94% and 31.88%, respectively. There was no significant difference between the two monomer groups.

[0078] 3.6 Changes in enzyme activity

[0079] Figure 4 C to D show the difference between rats with diarrhea induced by castor oil and rats without induced diarrhea (Na + / K + -ATPase 115.299±5.74912U / g, creatine kinase 17.514±0.3442U / L), Na + / K + -ATPase (76.38±2.4278U / g) and creatine kinase activity (15.478±0.30831U / L) were significantly decreased (p<0.05). Rats. However, luteolin and baicalein significantly increased the activities of both enzymes (p<0.05). At the same time, luteolin was better than baicalein due to its better ability to bind to Na+ / K+-ATPase.

[0080] 3.7 Changes in enzyme gene levels

[0081] In order to investigate whether baicalein and luteolin regulate Na + / K + -ATPase and creatine kinase activity, thereby exerting an anti-diarrhea effect. Real-time quantitative PCR was used to detect the mRNA levels of ckb and Atp1b3 in the intestinal tissues of drug-treated and untreated rats. Figure 4 As can be seen in (G), castor oil down-regulated the gene expression of ckb and Atp1b3, while luteolin and baicalein up-regulated the levels of these two genes. In the regulation of these two genes, baicalein had a better effect than luteolin.

[0082] 3.8 Changes in ion concentration

[0083] according to Figure 4 E-F, there were significant differences between the model group and the blank group, which means that castor oil reduced the concentrations of sodium and potassium ions in the small intestine. At the same time, luteolin and scutellariae increased Na + and K + concentrations, and the effects were similar.

[0084] Table 2 Primer sequences used for real-time quantitative PCR analysis

[0085]

[0086] 3.9 Changes in intestinal motility

[0087] Changes in intestinal motility are mainly assessed by the rate of carbon powder advancement. Figure 5 As shown, although the carbon powder propulsion rates of the luteolin and baicalein groups were slightly lower than those of the model group, there was no significant difference between them, suggesting that the two monomers may not bind well to opioid receptors, which is consistent with the results of the initial diarrhea time.

Claims

1. Use of baicalein in the preparation of anti-diarrhea drugs.